Coinsurance - The Other Reinsurance: Presentation To The Presentation To The Actuarial Institute of The Republic of China
Coinsurance - The Other Reinsurance: Presentation To The Presentation To The Actuarial Institute of The Republic of China
Coinsurance - The Other Reinsurance: Presentation To The Presentation To The Actuarial Institute of The Republic of China
Presentation to the
Actuarial Institute of the Republic of China
Agenda
Forms of Reinsurance – Beyond Risk-Premium Reinsurance
Why Coinsurance?
Considerations when Using Coinsurance
Uses of Coinsurance – Case Studies
P.1
Forms of Reinsurance
Beyond Risk-Premium Reinsurance
Forms of Reinsurance
Summary and Nicknames
Yearly Renewable Term (“YRT”):
Premium paid in return for mortality or morbidity coverage only
Often referred to as “risk-premium reinsurance”
Coinsurance (“Co”):
Share of g
gross p
premium in return for coverage
g of all benefits
Sometimes referred to as “original terms reinsurance”
Coinsurance with Funds Withheld (“Co FW”):
Coinsurance but ceding company keeps assets
Also referred to as “coinsurance with deposit back”
Modified Coinsurance (“Modco”):
Coinsurance but ceding company keeps assets and reserves
P.2
Forms of Reinsurance
YRT Reinsurance
Ceding company pays reinsurer a premium, less any allowances, to
cover reinsured mortality (or morbidity) claims
Reinsurer pays only mortality (or morbidity) claims, and does not pay
other benefits such as surrender benefits
Allowances and/or profit sharing may be paid to ceding company
Forms of Reinsurance
Coinsurance
Ceding company pays reinsurer (quota share of) all policyholder
premiums or considerations
Reinsurer
R i pays ceding
di company (quota
( t share
h of)
f) allll benefits
b fit paid
id tto
policyholders
Not just mortality or morbidity claims
Also
Al iincludes
l d surrender d bbenefits,
fit iinterest
t t credited
dit d (i
(implicitly),
li itl ) etc.
t
Reinsurer pays an allowance / ceding commission designed to cover
ceding company’s expenses + profit share; however:
Upfront / first-year ceding commission can be positive or negative
Upfront / first-year ceding commission can be greater than, less than, or equal to
ceding company’s acquisition costs
Assets and reserves are transferred to the reinsurer
Reinsurer holds reserves for its share of the business
P.3
Forms of Reinsurance
Coinsurance Cash Flows
Ceding Company pays Reinsurer (quota share of):
Policyholder Premiums
Initial Consideration ((if an in-force block transaction))
Reinsurer pays Ceding Company (quota share of):
Mortality / morbidity benefits
Surrender benefits
Oth benefits
Other b fit
Expense Allowances:
First-year ceding commission
Can be less than, equal to, or greater than ceding company’s actual
acquisition
i iti costs
t
Can be positive or negative
Initial ceding commission (if an in-force block transaction)
Can be less than, equal to, or greater than ceding company’s unamortized
acquisition
i iti costs
t
Can be positive or negative
Renewal-year expense allowances
Designed to cover fully allocated renewal-year expenses + commissions
Trail commission (maybe)
7
Forms of Reinsurance
Coinsurance Cash Flows
Initial First Year Renewal Year
C di C
Ceding Company C di C
Ceding Company C di C
Ceding Company
Benefits + Benefits +
Initial Initial Ceding Policyholder First-Year Policyholder Expense
Consideration Commission Premiums Ceding Premiums Allowances +
Commission T il
Trail
Commission
P.4
Forms of Reinsurance
Coinsurance Cash Flows – New Business Transaction
Initial 1 2 3
CEDING COMPANY PAYS:
Initial Consideration
Policyholder Premiums 100 95 90
TOTAL PAYMENTS FROM CEDING COMPANY - 100 95 90
REINSURER PAYS:
Mortality Benefits 1 2 3
Morbidity Benefits
Surrender Benefits 5 5 5
Other Benefits
SUBTOTAL - BENEFITS - 6 7 8
Forms of Reinsurance
Coinsurance Cash Flows – In-Force Block Transaction
Initial 1 2 3
CEDING COMPANY PAYS:
Initial Consideration 1,000
Policyholder Premiums 15 10 5
TOTAL PAYMENTS FROM CEDING COMPANY 1,000 15 10 5
REINSURER PAYS:
Mortality Benefits 10 12 15
Morbidity Benefits
Surrender Benefits 5 5 5
Other Benefits
SUBTOTAL - BENEFITS - 15 17 20
NET PAYMENT FROM CEDING COMPANY TO REINSURER 800 (20) (27) (35)
10
P.5
Forms of Reinsurance
Coinsurance versus YRT / Risk-Premium Reinsurance
Risk-Premium Reinsurance Coinsurance
Forms of Reinsurance
Variants of Coinsurance
Key differences from pure coinsurance are whether the ceding
company keeps the assets and/or reserves
All three are economically equivalent
Assuming the same interest rate on reserves / funds-withheld balance / modco
reserve
12
P.6
Why Coinsurance?
Going Beyond Risk-Premium Reinsurance
13
Why Coinsurance?
Reasons to Consider Coinsurance vs. YRT
Reserve and/or Capital Relief
For some products – especially accumulation products – the portion of the
reserve and/or
d/ capital
it l corresponding
di tto mortality
t lit or morbidity
bidit risks
i k can b
be a
fraction of the total reserve and/or capital
Risk Transfer
Some risks that the ceding company may not be comfortable with – investment
risk, surrender / lapse risk, etc. – cannot easily be transferred via YRT
reinsurance
Ceding
C di C Commission
i i
To the extent a ceding company seeks a sizeable ceding commission or override,
there may be a lot more profits available under a coinsurance structure, which, in
turn leads to a higher potential ceding commission
turn,
14
P.7
Why Coinsurance?
Reasons to Consider Coinsurance
Capacity for asset-intensive (e.g., savings) products
Companies don’t want to write too much of this business for capital / rating agency /
other reasons, but have to keep their distributors happy
Reinsurance can act as a “capacity valve” to allow a company to tailor their level of
production to a desired level
Capital relief
For products that are capital-intensive, coinsurance can help alleviate that strain
without having to limit sales
Reinsurer may have a different view of capital intensity due to different accounting or
solvencyy margin
g constraints
Signaling effect
A coinsurance treaty tells management, Board of Directors, regulators, rating agencies,
etc. that a third party stands behind your pricing and is willing to put their own capital
b hi d th
behind thatt b
belief
li f
This is because the reinsurer is economically in the same position as the ceding
company
p
This works especially y well when the reinsurer has helped
p to develop p the pproduct
Rather than taking consulting fees, the reinsurer is betting on the success of the
product right alongside the ceding company
15
Why Coinsurance?
Reasons to Consider Coinsurance (continued)
Investments expertise / ability or willingness to take risk
Reinsurer may have different constraints on investment risk
Willingness or ability to invest in different currencies
Access to various asset classes
Willingness to invest in alternative asset classes
Access to various hedging or derivative strategies
Different capital constraints
Ceding company may be limited by availability of various asset classes,
regulatory restrictions, management or Board preferences, rating-agency
constraints, etc.
16
P.8
Considerations when Using Coinsurance
17
18
P.9
Considerations when Using Coinsurance
Investments (continued)
Regular communication between ceding company’s and reinsurer’s
investments professionals
Depending on nature of the reinsurance treaty, may need a separate
/ segregated asset portfolio
Reinsurer can consider designating the ceding company (or an
asset-management affiliate of the ceding company) as the
investment manager for the coinsured asset portfolio
Reinsurer can receive the initial consideration in the form of:
Cash
Actual assets transferred (at market value – need to consider accounting impacts
if the assets are not currently held at market value by the ceding company)
Any combination thereof
19
20
P.10
Considerations when Using Coinsurance
Managing Counterparty Risk
Without further steps, coinsurance creates a large counterparty
exposure for the ceding company facing the reinsurer
There are a number of different ways to handle this risk:
Assets in trust
Other collateral such as letters of credit
Use of special-purpose reinsurance vehicle (SPRV)
21
22
P.11
Considerations when Using Coinsurance
Managing Counterparty Risk – Use of Special-Purpose Reinsurance Vehicle
24
P.12
Considerations when Using Coinsurance
Finance, Valuation, and Solvency
A lot more entries in the accounting ledgers
Consider tax implications
p carefully
y
Need to make sure that valuation software can handle the
reinsurance appropriately
May need some modifications
Consider solvency margin impacts carefully
Both local solvency margin, rating agency capital, etc.
25
P.13
Uses of Coinsurance
Case Studies
27
P.14
Uses of Coinsurance – Case Studies
Fixed Deferred Annuity In-Force Block (United States) – Considerations
Rationale: Statutory capital requirement for long term disabled life reserves is
very high
Transaction Structure: Full-risk coinsurance
95% quota share on in-force block of disabled lives
Assets and reserves transferred to RGA representing the current
reserves for paying the future claims of the disabled lives
RGA responsible for all future claim payments on reinsured block
Experience Refund = X% x (Expected Claims – Actual Claims)
Recapture not allowed except in very limited circumstances, such as
insolvency
Risk Transfer: Full risk transfer to RGA
Risks transferred: morbidity, mortality, inflation, investment (interest
rates, credit spreads)
Capital Impact: No impact on P&L as reserves transferred to RGA were equal to the
statutory reserves
Client able to free up regulatory capital (around 40% of reserves)
30
P.15
Uses of Coinsurance – Case Studies
Seasoned Disabled Life Reserves In-Force Block (Australia) – Considerations
31
Capital Impact: Client sets up minimal capital for the reinsured quota share
Clientt receives
Cli i ttrailil commissions
i i ffor lif
life off product
d t on reinsured
i d portion
ti
32
P.16
Uses of Coinsurance – Case Studies
Savings / Long-Term Care Product Development (Japan) – Considerations
Product development
RGA conducted several “Voice of the Channel” exercises to determine product
ideas that agents were interested in
RGA provided the majority of the material the client needed to file the product
with the regulator
Concept developed was to not credit anyy interest (i.e.,
( return of premium after 10
years) to avoid competing with aggressive Japanese domestics
Instead, a sizeable lump sum LTC benefit is provided
Investment strategy
Purchase of duration matched JGBs combined with the sale of credit default
swaps to increase the yield
Very difficult to earn a spread over JGBs with other strategies
No
N collateral
ll t l requirements:
i t
Reinsurer is large, “onshore” rated entity
Not huge premium amounts to start with → little counterparty risk
Allows
Allo s for modest uplift
plift in pricing → higher ceding commission
33
Conclusion
34
P.17
Coinsurance – The Other Reinsurance
Conclusion
It’s important to consider coinsurance in addition to YRT or risk-
premium reinsurance, as coinsurance gives the possibility of
Higher ceding commissions;
More risks transferred to the reinsurer; and
More reserve and/or capital relief
There are a number of additional items for a ceding company to
consider with a coinsurance treaty, including:
Investments
Treatment of non-guaranteed elements
Managing counterparty risk
Reporting administration
Reporting, administration, finance,
finance valuation,
valuation and solvency
Coinsurance is an extremely powerful tool that can help solve some
of today’s most pressing problems for life insurance companies
35
P.18
The ComFrame Initiative
From the International Association
From the International Association
of Insurance Supervisors
Presented by Tom Herget, FSA, MAAA, CERA
Actuarial Institute of Chinese Taipei April 26, 2013
ComFrame
ComFrame
Common Framework for the Supervision of Internationally
Active Insurance Groups
P.19
Introduction to the International
Association of Insurance Supervisors
p
P.20
IAIS: standard setter for insurance
supervision
• Founded in 1994
• Members from more than 200 jurisdictions in over 140
countries – all regions; all types of markets
• Around 150 Observers
• Hosted by the Bank for International Settlements (BIS)
in Basel
• MoU with IAA
Membership
classes
Members Observers
National Federal
International Other
Insurance Association of Insurance
Governmental/ interested
Supervisors Insurance Office of the US
Statutory bodies parties
Commissioners Dept. of Treasury
IAIS objectives
j
P li h ld protection
Policyholder t ti Efficient fair,
Efficient, fair safe and
stable insurance markets
Improved supervision
P.21
IAIS Roles and activities
Identify
potential risks
that may affect
insurance
Encourage co- supervision
Represent field
operation of insurance
amongst Cooperate with supervision
i i
insurance other
supervisors international
organisations
i ti
IAIS Organisation
g Structure
General Meeting
Supervisory Cooperation
ComFrame Oversight
Subcommittee
Solvency
S l & Actuarial
A t i l IIssues
Subcommittee
8
P.22
IAIS Organisation
g
Staff
Staff of 25, all in Basel
Revenues ($000)
from Members:135 pay around $25; 13 pay $70;
from Members:135 pay around $25; 13 pay $70;
One pays $300 (Total $ 3,600)
from Observers: about 160 pay $15 (Total $2,200)
US input
• Members: 58 states, Federal, NAIC
• Observers: about 40
• AAA: through IAA
ComFrame
ComFrame aims to
Develop methods of operating group‐wide supervision of
Internationally Active Insurance Groups (IAIGs) in order to make
group‐wide supervision more effective and more reflective of actual
d ff d fl f l
business practices
EEstablish a comprehensive framework for supervisors to address
t bli h h i f kf i t dd
group‐wide activities and risks and also set grounds for better
supervisory cooperation in order to allow for a more integrated and
international approach
international approach
Foster global convergence of regulatory and supervisory measures
and approaches
and approaches
P.23
ComFrame
ComFrame should
be specific, but not rules‐based
be ever‐evolving (and further look into case experiences)
b l i ( df h l ki i )
be developed in close collaboration with interested stakeholders
lead to more consistency and better comparability and alignment regarding the
supervision of internationally active insurance groups being undertaken by each
jurisdiction
ComFrame
Timeline
Concept Paper
ComFrame is to be developed within 3 years (“Development Phase”) starting
July 1, 2010
At the end of the first year from the starting date, a comprehensive and in‐
depth Concept Paper is to be be available
Immediately following the three‐year Development Phase, impact assessments
including those on calibrations (particularly for quantitative requirements) will
be undertaken (“Field
be undertaken ( Field Testing Phase
Testing Phase”, formerly
formerly “Calibration
Calibration Phase
Phase”))
P.24
ComFrame
Module 1 Scope of ComFrame
Element 1 Identification of IAIGs
Element 2 Process of identifying IAIGs
p p
Element 3 Scope of ComFrame supervision
Element 4 Identification of the group‐wide supervisor and involved supervisors
Module 2 The IAIG
Module 2 The IAIG
Group Governance Element 1 Governance
Group ERM Element 2 Enterprise Risk Management
Group Structure and Strategy
Group Structure and Strategy
Element 3 IAIG’s legal and management structures from an ERM perspective
Element 4 IAIG’s strategy from an ERM perspective
Element 5 Intra‐group
Element 5 Intra group transactions and exposures from an ERM perspective
transactions and exposures from an ERM perspective
Group Financial Condition
Element 6 Liabilities/technical provisions and assets/investments
Element 7 Valuation
Element 8 Group Capital Adequacy Assessment
Group Reporting and Disclosure Element 9 Reporting and disclosure
ComFrame
Module 3 The Supervisors
Module 3 The Supervisors
Group‐wide supervisory process
Element 1 Group‐wide supervisory process
Supervisory Cooperation
Element 2 Cooperation and coordination including reliance and recognition
Element 3 Roles of group‐wide supervisor and involved supervisors
Element 4 Use of Supervisory Colleges
Crisis Management and Resolution
Element 5 Crisis management among supervisors
Element 6 IAIGs and resolution
Module 4 Implementation of ComFrame
Element 1 Applicability of ComFrame to all IAIS jurisdictions
Element 1 Applicability of ComFrame to all IAIS jurisdictions
P.25
ComFrame
ComFrame Working Draft dated July 2, 2012
179 pages
Comment period July 1 through August 31
C i dJ l 1 h hA 31
Comments from AAA, CIA, IAA, NAIC, ACLI, GNAIE and many others
Over a thousand comments (358 pages) on the original 180 page document
ComFrame
Highlights of Comments (1 of 6)
Member overarching themes (expressed often but not necessarily
b hi h ( d f b il
by a majority)
1 Don’t use CF to expand ICPs
2 Don’t repeat/duplicate ICPs
3 Simplify
4 Ambiguous terminology
5 Power and authority issues
6 Lake of clarity about where CF requirements are meant to apply (lead
L k f l it b t h CF i t tt l (l d
supervisor, all supervisors, the iaig, the subsidiaries)
7 Field testing will be important
Field testing will be important
P.26
ComFrame
Highlights of Comments (2 of 6)
Member comments at opposite ends of spectrum
1 Converge CF rules vs. use regulations of home country
2 Flexibility vs. consistency
3 Level playing field between iaig’s and non‐iaig’s
4 Role of group supervisor – specified or negotiated
5 Reporting requirements too detailed; detail needed for commonality
6 Criteria too prescriptive; others comfortable
7 Lack of progress on capital adequacy element; others comfortable
8 CF should foster mutual understanding of different capital requirements
8 CF h ld f t t l d t di f diff t it l i t
but others say capital requirements should be consistent across iaig’s
ComFrame
Highlights of Comments (3 of 6)
Observer overarching themes
1 Many observer comments stem from differences in opinion on purpose of CF
2 CF focus: focus on module 3 (supervisory cooperation); module 2 too
prescriptive
3 Field testing / impact assessment should begin asap; do pilot
4 Need clearer CF goals articulation
5 IAIG criteria: firm up determination; net too big
IAIG i i fi d i i bi
6 Supervisory resources ‐ do they currently have the resources to implement
7 Confidentiality
8 No blurring lines between gsii and iaig
No blurring lines between gsii and iaig
P.27
ComFrame
Highlights of Comments (4 of 6)
Observer comments at opposite ends of the spectrum
1 Level playing field vs. flexibility
2 Highly prescribed requirements on supervisors vs. flexibility
Highly prescribed requirements on supervisors vs. flexibility
ComFrame
Highlights of Comments (5 of 6)
Valuation (module 7)
1 Sole use of IFRS is now in question
2 Mention no accounting standard
3 Various options for an accounting basis
4 Keep IFRS ‐ G20 advanced use of 1 set of global accounting standards as
they measure of post‐crisis reforms
5 Don’t need prudential filters; others say we do so supervisors don’t do their own
thing
6 Where to place filters – to the accounting basis or to the resulting capital
resources
P.28
ComFrame
Highlights of Comments (6 of 6)
Capital Adequacy (module 8)
1 CF may not be right place to develop a global capital standard
2 Strong opposition from some Observers to a capital requirement
3 Use group‐wide capital requirements of group supervisor
4 Focus more on understanding different approaches
5 Lamenting slow progress on developing capital adequacy
L i l d l i i l d
6 Don’t work on capital adequacy until global accounting basis is settled
7 IAIG competitiveness against insurers not subject to CF
8 Reference to tiered capital (as in banks) not appropriate for insurers
Reference to tiered capital (as in banks) not appropriate for insurers
ComFrame
Timeline from here on out (1 of 2)
• April ‐ Further refinements of the drafts will be discussed in April working party
meetings
• May ‐ There is a key TC meeting in May to discuss outstanding issues. Working
parties will be meeting too. A full draft made available to Observers
• June ‐ The TC meeting in May will hopefully approve a 2013 Draft ComFrame for
consultation from July to the end of August 2013 (final consultation in the
l i f J l h d fA 2013 (fi l l i i h
Development Phase)
P.29
ComFrame
Timeline from here on out (2 of 2)
• Summer – Preparation of a comprehensive report on comments for the General
Meeting in 2013
• December – Sign off by Executive Committee on the comprehensive report on
the end of the Development phase
ComFrame
Way forward with Stress / Scenario Testing
• Scenarios are projections of financial outcomes for the group/entity
g ,
• Focus on extreme negative scenarios, which are stressed to examine close
to the full range of extreme possibilities
• The company should survive 99.5% of the possibilities
• The NAIC would like to remove the one in two hundred reference with
something like “events that occur only rarely, such as once in every 200
years.” The reliability in the tail is not as good as we think.
• Supervisors would dictate three types of scenarios:
• Global (e.g. financial, pandemic, man‐made catastrophe or natural
catastrophe),
• Jurisdictional, and
• Group‐specific
P.30
ComFrame
Need a common valuation basis
• Originally was going to utilize the accounting for the IASB’s insurance accounting
project
• World‐wide adoption of a single standard is now in doubt
• Currently in contemplation is a ComFrame Adjusted Balance Sheet (CABS)
Japanese Regulatory
US GAAP
G
GAAP The interim (IFRS 4 phase I) standard allows insurance B
Bases
undertakings to maintain prior used accounting practices for
insurance liabilities (IFRS 4.22 ff.). This could result in a lack of
comparability concerning the measurement of insurance liabilities.
Accounting (incl.
Capital Resources)
j
adjustments
CABS for IAIG
GWS/Supervisory College
/ p y g
KEY:
KEY
including Capital CABS = ComFrame Adjusted
Assessment(s)/Judgements Balance Sheet
Blue = Prepared by IAIG
Green = Prepared by Supervisors
Red = Results: actions by the
Scenarios, Accounting adjustments, Group Wide Supervisor &/or
Supervisory College
Capital Resources – set the uniform
methodology and any supporting
requirements 4/15/2013
P.31
Draft for discussion
IFRS
The interim (IFRS 4 phase I) standard allows insurance undertakings to
The interim (IFRS 4 phase I) standard allows insurance undertakings to
Japanese Regulatory
US GAAP maintain prior used accounting practices for insurance liabilities (IFRS 4.22
GAAP Bases
ff.). This could result in a lack of comparability concerning the measurement
of insurance liabilities.
- Goodwill (% of capital)
- Deferred tax assets (% of capital)
- Other intangible assets
+ Risk margin on property/casualty reserves (where clearly identifiable)
nting Adju
ComFrame
Overarching Issues
• We seem to be developing a minimum capital
• Evaluate at just the holding company level or at each subsidiary?
• How to handle non‐insurance companies that could impact the insurance
companies
• What is the accounting basis for this since IFRS no longer a viable option (TH
suggestion: just do assets and cash)
i j d d h)
• Members think that field testing will shed much light
P.32
ComFrame
Four Key Issues
• Where, in the organization structure, to define the insurance holding company?
At the lowest level holding company that owns all the insurers in the group.
Naturally, you would have to watch for impacts from other affiliates
• Financial Assets. Fair Value vs. Amortized Costs (can be appropriate for long
term business)
• Technical Provisions (reserves) (liabilities). Discounting for property & casualty
reserves? Discount rate for long‐term life liabilities?
? Di f l lif li bili i ?
• Deferred Tax Assets. Most would disallow, but might be more significant if P&C
reserve discounting introduced
reserve discounting introduced
ComFrame
Field Testing ‐ Objectives
• Objective ‐ To perform impact studies of all elements* of the draft ComFrame
resulting from the Development Phase, to test if they
lead to effective group‐wide supervision of IAIGs,
are practical, and
do not lead to excessive costs to IAIGs and their supervisory colleges
• Objective ‐ To assess the results of such field testing so that the IAIS can
determine any evidence‐based changes that are necessary to the draft ComFrame
i i
in view of a target date of adoption at the 2018 General Meeting
f d f d i h 2018 G lM i
•• Field Testing Task Force chair and vice chair appointed; committee being
Field Testing Task Force chair and vice chair appointed; committee being
populated
P.33
ComFrame
Field Testing ‐ Timeline
• Spring, summer 2013 – how to do it
• Summer, fall 2013 – selection of volunteer iaig’s
• 2014 – perform the field testing
ComFrame
Field Testing – how the IAA may assist
• We have “seat at the table” on the SSC – perhaps get on the FTTF
• Develop prototype understanding of deliverables
• Develop case studies to simulate situations CF could address without waiting for
year‐long FT turnaround
P.34
Progress on Insurance
C t t Accounting
Contracts A ti
IFRS and FASB
April 26, 2013
Presented to
IASB
• Formed April 1, 2001, assuming standards setting
from
o IASC.SC. Governments
Gove e s dictate
d c a e requirements.
equ e e s. IFRS
S
is used in Europe because EU requires it.
• 16 international members – limited insurance
company experience
• Actions taken at monthly meetings
• Staff in London; most meetings in London
• www.IFRS.org
www IFRS org
P.35
3
FASB
• Formed 1973; 7 members
• Actions taken at weekly meetings
• Staff in Connecticut; most meetings in Connecticut
(or in London if joint with IASB)
• SEC delegates standard setting to FASB; FAS is used
in the US because SEC requires it.
it
• SEC accepts IFRS from foreign registrants and is
considering accepting IFRS for US registrants
• www.FASB.org
Timeline
• IASB
▫ Spring 2007: Phase II Discussion Paper
▫ July
y 2010: Insurance Standard Exposure
p Draft
▫ June 2013: Re-exposure
▫ 2014:
0 : IASBS Insurance
su a ce Contract
Co t act Sta
Standard
da d
▫ 2018?: Insurance Standard Effective
• FASB
▫ September 2010: Insurance Discussion Paper
▫ July 2013: FASB Exposure Draft
▫ 2014: FASB Insurance Standard
▫ 2018?: Insurance Standard Effective
P.36
5
P.37
7
P.38
9
10
Acquisition Costs
12
P.40
13
14
P.41
15
16
P.42
Key FASB-IASB Differences
• One margin vs. a Risk Adjustment and a Residual
Margin
ag
18
Presentation
P.43
19
Investments
• Instructions come from IFRS 9, which replaces IAS
37 noo later
a e than
a 2015
0 5
20
Investments - Measurement
• Debt instruments (bonds, mortgages) are on
Amortized
o ed Cost
Cos (AC)
( C)
▫ An option – you can use Fair Value (FV) if you can
demonstrate that this avoids an accountingg mismatch
(they support insurance liabilities that move with FV).
All income goes through profit / loss
▫ Another option – report FV, but also calculate AC.
AC is used for profit/loss, but mark to market and
report that difference in OCI
• Equities and derivatives – at FV (and all impact goes
through profit loss
P.44
21
Assets
Reinsurance assets XX
Other assets XX
Total assets XXX
Liabilities
Li biliti
Insurance contract liabilities XX
Other liabilities XX
Total liabilities XX
Equity XX
Total equity and liabilities XXX
P.45
IFRS Presentation Income Statement - OCI
▫ Pause – just what is OCI?
▫ CI = PL plus OCI
▫ Comprehensive Income, Profit Loss
▫ Again, just what is OCI?
▫ In the major accounting bases, there is no articulation of philosophy in
ascribing elements to OCI
▫ Investors tend to look at PL as gauge of performance
▫ How to assign? Blanket or principles?
▫ Possible principles
Warranted vs. unwarranted volatility
Actions within vs. outside of management control
Ordinary (usual) vs. extraordinary (unusual) events
Regular results vs. those induced by changes in methodologies or
assumptions
Current year results vs. prior period adjustment
24
Investment income X
Interest on insurance liability (X)
Net interest and investment X
Profit or loss X
P.46
Presentation – Revenue
• Premium element of revenue stream will look like YRT
premiums
▫ Do not include portion of premium that is deposit-like (e.g.
account values for UL policies) (“dis-aggregate”)
• Cannot
C be
b derived
d i d ffrom collected
ll d andd ddoesn’t
’ affect
ff bbottom
line
• Most items in income statement will come from actuaries
Presentation – FAS60
• Premium 100
• Investment income 10
▫ Revenue 110
• Death claims 15
• Expenses 20
• C h value
Cash l paidid 5
• Increase in Reserves 55
▫ Expense 95
• Profit 15
P.47
Presentation – FAS97
• COI charge 25
• Expense load charge 10
• Investment income 10
▫ Revenue 45
• Profit 15
Presentation – IFRS
• Residual Margin released 4
• Change in Risk Adjustment 6
• p
Expected claims 5
• Expected expenses 20
▫ Revenue 35
• Claims 5
• Expenses 20
▫ Claims and expenses 25
• Underwriting profit 10
• dsf
• I
Investment
t t Income
I 10
• Interest credited to liabilities 5
• Investment profit 5
• Total profit 15
P.48
30
Disclosures
• Premiums, claims
• Expected PV of future payments and receipts
• Changes in the amount of risk
• Effects of new contracts written
• Processes for estimating inputs and methods used
• Effect of changes in methods and inputs used
• Explanation of reasons for change & identification of contracts
affected
• Nature
N t andd extent
t t off risks
ik
• Extent of mitigation of risks (reinsurance, participation)
• Quantitative information about exposure to credit,
credit market and
liquidity risk
P.49
31
Transition
Transition
• Measure the present value of fulfillment cash flows using
current estimates
• Derecognize current DAC balances
• Determine the single or residual margin:
▫ Through retrospective application of new principles to
all prior periods where it is practical to do so
▫ For earlier periods where the retrospective application
is not practical, estimate the margin
• Determine
D i the
h discount
di rate for
f a minimum
i i off 3 years
▫ Use difference from a reference rate for prior periods if
necessary
P.50
Recap - Timeline
• New IFRS ED for Insurance Contracts May or June 2013
▫ This will be an Exposure Draft but they are only asking for
comments on five areas:
Presentation of premium
Unlocking residual margin
Changes in discount rate go through OCI
Transition requirements
Participating contract mirroring
▫ Will read all comments received
▫ 120 day exposure period
• FASB Exposure Draft for Insurance Contracts expected
J l 2013
July
▫ Asking for comments on entire ED
• Final standards adopted in 2014; effective in 2018?
34
P.52